Literature DB >> 25113794

7T T₂*-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease.

Sanneke van Rooden1, Nhat Trung Doan2, Maarten J Versluis3, Jeroen D C Goos4, Andrew G Webb3, Ania M Oleksik5, Wiesje M van der Flier6, Philip Scheltens4, Frederik Barkhof7, Annelies W E Weverling-Rynsburger8, Gerard Jan Blauw9, Johan H C Reiber2, Mark A van Buchem3, Julien Milles2, Jeroen van der Grond3.   

Abstract

The aim of this study is to explore regional iron-related differences in the cerebral cortex, indicative of Alzheimer's disease pathology, between early- and late-onset Alzheimer's disease (EOAD, LOAD, respectively) patients using 7T magnetic resonance phase images. High-resolution T2(∗)-weighted scans were acquired in 12 EOAD patients and 17 LOAD patients with mild to moderate disease and 27 healthy elderly control subjects. Lobar peak-to-peak phase shifts and regional mean phase contrasts were computed. An increased peak-to-peak phase shift was found for all lobar regions in EOAD patients compared with LOAD patients (p < 0.05). Regional mean phase contrast in EOAD patients was higher than in LOAD patients in the superior medial and middle frontal gyrus, anterior and middle cingulate gyrus, postcentral gyrus, superior and inferior parietal gyrus, and precuneus (p ≤ 0.042). These data suggest that EOAD patients have an increased iron accumulation, possibly related to an increased amyloid deposition, in specific cortical regions as compared with LOAD patients.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AD pathology; Alzheimer's disease; Brain imaging; Early-onset AD; Human 7T MRI; Phase

Mesh:

Substances:

Year:  2014        PMID: 25113794     DOI: 10.1016/j.neurobiolaging.2014.07.006

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  23 in total

1.  Motor cortex hypointensity on susceptibility-weighted imaging: a potential imaging marker of iron accumulation in patients with cognitive impairment.

Authors:  Mina Park; Yeonsil Moon; Seol-Heui Han; Won-Jin Moon
Journal:  Neuroradiology       Date:  2019-01-28       Impact factor: 2.804

Review 2.  Treating Alzheimer's disease by targeting iron.

Authors:  Sara Nikseresht; Ashley I Bush; Scott Ayton
Journal:  Br J Pharmacol       Date:  2019-02-11       Impact factor: 8.739

Review 3.  Contributions to magnetic susceptibility of brain tissue.

Authors:  Jeff H Duyn; John Schenck
Journal:  NMR Biomed       Date:  2016-05-30       Impact factor: 4.044

Review 4.  Ischemic brain injury in cerebral amyloid angiopathy.

Authors:  Yael D Reijmer; Susanne J van Veluw; Steven M Greenberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

5.  Present and Future of Ultra-High Field MRI in Neurodegenerative Disorders.

Authors:  Graziella Donatelli; Roberto Ceravolo; Daniela Frosini; Michela Tosetti; Ubaldo Bonuccelli; Mirco Cosottini
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-20       Impact factor: 5.081

6.  Quantitative susceptibility mapping demonstrates different patterns of iron overload in subtypes of early-onset Alzheimer's disease.

Authors:  Grégory Kuchcinski; Lucas Patin; Renaud Lopes; Mélanie Leroy; Xavier Delbeuck; Adeline Rollin-Sillaire; Thibaud Lebouvier; Yi Wang; Pascal Spincemaille; Thomas Tourdias; Lotfi Hacein-Bey; David Devos; Florence Pasquier; Xavier Leclerc; Jean-Pierre Pruvo; Sébastien Verclytte
Journal:  Eur Radiol       Date:  2022-07-26       Impact factor: 7.034

Review 7.  Contribution of metals to brain MR signal intensity: review articles.

Authors:  Tomonori Kanda; Yudai Nakai; Shuri Aoki; Hiroshi Oba; Keiko Toyoda; Kazuhiro Kitajima; Shigeru Furui
Journal:  Jpn J Radiol       Date:  2016-03-01       Impact factor: 2.374

Review 8.  Role of iron in neurodegenerative diseases.

Authors:  Kai Li; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2016-01-21       Impact factor: 3.575

9.  Treadmill Exercise Alleviates Brain Iron Dyshomeostasis Accelerating Neuronal Amyloid-β Production, Neuronal Cell Death, and Cognitive Impairment in Transgenic Mice Model of Alzheimer's Disease.

Authors:  Dong-Hun Choi; Ki-Chun Kwon; Dong-Joo Hwang; Jung-Hoon Koo; Hyun-Seob Um; Hong-Sun Song; Ji-Sun Kim; Yongchul Jang; Joon-Yong Cho
Journal:  Mol Neurobiol       Date:  2021-02-28       Impact factor: 5.590

Review 10.  Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease.

Authors:  Andrew Gleason; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2020-10-27       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.